Skip to main content

Retinitis Pigmentosa clinical trials at UCSD

2 in progress, 0 open to eligible people

Showing trials for
  • OCU400 Gene Therapy for the Treatment Of Retinitis Pigmentosa

    Sorry, not currently recruiting here

    This is a Phase 3 study to Assess the Efficacy, Safety and Tolerability of OCU400 in patients with retinitis pigmentosa (RP) associated with RHO mutations and patients with any other RP associated mutation with a clinical phenotype of RP. This is a multicenter, assessor blinded and randomized study which will enroll 150 subjects.

    La Jolla, California and other locations

  • OCU400 for Retinitis Pigmentosa and Leber Congenital Amaurosis

    Sorry, in progress, not accepting new patients

    This is a Phase 1/2 Study to Assess the Safety and Efficacy of OCU400 in patients with retinitis pigmentosa associated with NR2E3 and RHO mutations and in patients with LCA due to mutation(s) in CEP290 gene (OCU400-101). To document prospective eye pathology in the above subjects Investigators will also conduct a Natural History Study (OCU400-104)i This is a multicenter study, which will be conducted in two phases and will enroll up to a total of 24 subjects in the OCU400-101 and 100 subjects in the OCU400-104 study.

    La Jolla, California and other locations

Last updated: